Clinical Trials Search Results

Display:

Title

Description with: Locations Eligibility

Full Trial Description

Custom

?

Hide Search Criteria

Show Search Criteria

Drug: necitumumab
Find trials that include: Any drugs shown

Results 1-4 of 4 for your search:

Start Over

Select All on Page Sort by: Show Results per Page

1.

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15529, NCI-2015-02258, I4X-MC-JFCP, NCT02392507

2.

Osimertinib and Necitumumab in Treating Patients with EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9898, NCI-2015-01053, PHI-77, NCT02496663

3.

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16088, NCI-2016-01008, 2016-000440-33, I8J-MC-JYCA, NCT02791334

4.

Afatinib and Necitumumab in Treating Patients with EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Status: Not yet active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: VICC THO 1684, NCI-2016-01532, NCT03054038

Select All on Page

Start Over